UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMERIPRISE FINANCIAL INC | 86,109 | $1,206,387 | 0.00% |
| TORONTO DOMINION BANK | 6 | $84 | 0.00% |
| DEUTSCHE BANK AG\ | 10,514 | $147,301 | 0.00% |
| CITIGROUP INC | 406 | $5,688 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 46,394 | $649,980 | 0.00% |
| GOLDMAN SACHS GROUP INC | 53,647 | $751,594 | 0.00% |
| MORGAN STANLEY | 111,127 | $1,556,890 | 0.00% |
External links
This page lists UROGEN PHARMA LTD's shareholders in Q3 2023. To view UROGEN PHARMA LTD's shareholder history, click here.